- Home
- AUTL vs NXJ Comparison
AUTL vs NXJ Comparison
Compare AUTL & NXJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- NXJ
- Stock Information
- Founded
- AUTL 2014
- NXJ 1999
- Country
- AUTL United Kingdom
- NXJ United States
- Employees
- AUTL N/A
- NXJ N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- NXJ Finance/Investors Services
- Sector
- AUTL Health Care
- NXJ Finance
- Exchange
- AUTL Nasdaq
- NXJ Nasdaq
- Market Cap
- AUTL 609.4M
- NXJ 492.3M
- IPO Year
- AUTL 2018
- NXJ N/A
- Fundamental
- Price
- AUTL $2.29
- NXJ $11.86
- Analyst Decision
- AUTL Strong Buy
- NXJ
- Analyst Count
- AUTL 3
- NXJ 0
- Target Price
- AUTL $10.20
- NXJ N/A
- AVG Volume (30 Days)
- AUTL 1.8M
- NXJ 74.9K
- Earning Date
- AUTL 11-12-2024
- NXJ 01-01-0001
- Dividend Yield
- AUTL N/A
- NXJ 3.27%
- EPS Growth
- AUTL N/A
- NXJ N/A
- EPS
- AUTL N/A
- NXJ N/A
- Revenue
- AUTL $10,091,000.00
- NXJ N/A
- Revenue This Year
- AUTL $940.05
- NXJ N/A
- Revenue Next Year
- AUTL $238.49
- NXJ N/A
- P/E Ratio
- AUTL N/A
- NXJ N/A
- Revenue Growth
- AUTL 82.71
- NXJ N/A
- 52 Week Low
- AUTL $2.20
- NXJ $10.06
- 52 Week High
- AUTL $7.45
- NXJ $12.24
- Technical
- Relative Strength Index (RSI)
- AUTL 28.90
- NXJ 24.48
- Support Level
- AUTL $2.44
- NXJ $12.60
- Resistance Level
- AUTL $2.97
- NXJ $12.73
- Average True Range (ATR)
- AUTL 0.18
- NXJ 0.14
- MACD
- AUTL -0.04
- NXJ -0.08
- Stochastic Oscillator
- AUTL 8.82
- NXJ 0.00
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About NXJ Nuveen New Jersey Qualified Municipal Fund
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.